๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Analysis of two-treatment, two-period crossover trials in emergency medicine

โœ Scribed by James F. Reed III


Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
77 KB
Volume
43
Category
Article
ISSN
1097-6760

No coin nor oath required. For personal study only.

โœฆ Synopsis


Analysis of Two-Treatment, Two-Period Crossover Trials in Emergency Medicine See related article, p. 6, and editorial, p. 15.


๐Ÿ“œ SIMILAR VOLUMES


Randomization and Additivity in the Two-
โœ Prof. Richard McHugh; Orlando Gomez-Marin ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 427 KB ๐Ÿ‘ 1 views

I n certain a r m of medical reeearch, the two-period CrOBBOVer deaign is a frequent choice for comparing treatmentsA and B in a randomized clinicel trial. Earlier work by Grizzle and by Brown WBB baaed upon a parametric theory linear model. Recenfly, the present authom employed D. R. Cox's additive

A Note on the Analysis of the Two-Period
โœ A. P. Grieve ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB ๐Ÿ‘ 2 views

In the analysis of a two-period cro88over study GBIZZLE (1965) suggeata that, if a preliminary k t for a period by treatment inbraction (residual effeot, carryover effect) fsignificant at the 10 o/o level, the direct effects of the treatments should be compared by performix$ a t -h t on the data fro

Hierarchical Bayesian analysis of the ca
โœ S.R. David; J.W. Seaman Jr. ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 809 KB

## In this paper, hierarchical Bayesian methods for the analysis of crossover designs are developed. First, we consider two hierarchical prior structures yielding posterior quantities that can be obtained via numerical integration. We illustrate this method with an analysis of two well-known data

A double-blind randomized crossover tria
โœ Vasavada, Nina; Saha, Chandan; Agarwal, Rajiv ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 275 KB

## Background: Torsemide has predictable absorption compared to furosemide. thereby, torsemide results in more constant exposure to active drug. our hypothesis was that this pharmacokinetic difference between these commonly used loop diuretics may translate into disparate antihypertensive responses